Tenax Therapeutics (TENX) Notes Payables: 2011-2013
Historic Notes Payables for Tenax Therapeutics (TENX) over the last 2 years, with Apr 2013 value amounting to $57,539.
- Tenax Therapeutics' Notes Payables fell 8.61% to $57,539 in Q2 2013 from the same period last year, while for Apr 2013 it was $57,539, marking a year-over-year decrease of 8.61%. This contributed to the annual value of $57,539 for FY2013, which is 8.61% down from last year.
- Per Tenax Therapeutics' latest filing, its Notes Payables stood at $57,539 for Q2 2013, which was down 41.68% from $98,657 recorded in Q1 2013.
- Tenax Therapeutics' Notes Payables' 5-year high stood at $104,178 during Q1 2012, with a 5-year trough of $7,195 in Q4 2011.
- Moreover, its 3-year median value for Notes Payables was $43,295 (2011), whereas its average is $46,504.
- As far as peak fluctuations go, Tenax Therapeutics' Notes Payables skyrocketed by 45.42% in 2012, and later dropped by 8.61% in 2013.
- Over the past 3 years, Tenax Therapeutics' Notes Payables (Quarterly) stood at $7,195 in 2011, then remained steady at $7,195 in 2012, then dropped by 8.61% to $57,539 in 2013.
- Its last three reported values are $57,539 in Q2 2013, $98,657 for Q1 2013, and $7,195 during Q4 2012.